Spots Global Cancer Trial Database for extraskeletal myxoid chondrosarcoma

Every month we try and update this database with for extraskeletal myxoid chondrosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas	NCT03600649	Ewing Sarcoma Myxoid Liposarc... Sarcoma,Soft Ti... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Primary Pulmona... Myoepithelial T... Sclerosing Epit... Fibromyxoid Tum...	Seclidemstat Cyclophosphamid... Topotecan	12 Years -	Salarius Pharmaceuticals, LLC
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery	NCT02180867	Alveolar Soft P... Angiomatoid Fib... Atypical Fibrox... Clear Cell Sarc... Epithelioid Mal... Epithelioid Sar... Extraskeletal M... Extraskeletal O... Fibrohistiocyti... Fibrosarcoma Inflammatory My... Intimal Sarcoma Leiomyosarcoma Liposarcoma Liver Embryonal... Low Grade Fibro... Low Grade Myofi... Malignant Cutan... Malignant Perip... Malignant Trito... Mesenchymal Cho... Myxofibrosarcom... Myxoid Chondros... Myxoinflammator... Nerve Sheath Ne... PEComa Pericytic Neopl... Plexiform Fibro... Sclerosing Epit... Skin Glomus Tum... Stage IB Soft T... Stage IIB Soft ... Stage III Soft ... Stage IV Soft T... Synovial Sarcom... Undifferentiate...	Doxorubicin Doxorubicin Hyd... Ifosfamide Pazopanib Pazopanib Hydro... Radiation Thera... Therapeutic Con...	2 Years -	National Cancer Institute (NCI)
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery	NCT02180867	Alveolar Soft P... Angiomatoid Fib... Atypical Fibrox... Clear Cell Sarc... Epithelioid Mal... Epithelioid Sar... Extraskeletal M... Extraskeletal O... Fibrohistiocyti... Fibrosarcoma Inflammatory My... Intimal Sarcoma Leiomyosarcoma Liposarcoma Liver Embryonal... Low Grade Fibro... Low Grade Myofi... Malignant Cutan... Malignant Perip... Malignant Trito... Mesenchymal Cho... Myxofibrosarcom... Myxoid Chondros... Myxoinflammator... Nerve Sheath Ne... PEComa Pericytic Neopl... Plexiform Fibro... Sclerosing Epit... Skin Glomus Tum... Stage IB Soft T... Stage IIB Soft ... Stage III Soft ... Stage IV Soft T... Synovial Sarcom... Undifferentiate...	Doxorubicin Doxorubicin Hyd... Ifosfamide Pazopanib Pazopanib Hydro... Radiation Thera... Therapeutic Con...	2 Years -	National Cancer Institute (NCI)
A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors	NCT05355753	Synovial Sarcom... Soft Tissue Sar...	CFT8634	12 Years -	C4 Therapeutics, Inc.
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)	NCT05266196	Ewing Sarcoma Myxoid Liposarc... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Myoepithelial T... Low Grade Fibro... Sclerosing Epit...	Seclidemstat	12 Years -	Salarius Pharmaceuticals, LLC
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas	NCT03600649	Ewing Sarcoma Myxoid Liposarc... Sarcoma,Soft Ti... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Primary Pulmona... Myoepithelial T... Sclerosing Epit... Fibromyxoid Tum...	Seclidemstat Cyclophosphamid... Topotecan	12 Years -	Salarius Pharmaceuticals, LLC
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)	NCT05266196	Ewing Sarcoma Myxoid Liposarc... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Myoepithelial T... Low Grade Fibro... Sclerosing Epit...	Seclidemstat	12 Years -	Salarius Pharmaceuticals, LLC
Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma	NCT02066285	Solitary Fibrou... Extraskeletal M...	Pazopanib	18 Years -	Grupo Espanol de Investigacion en Sarcomas

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: